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“There is plenty of room at the bottom”
Feynman, 1959
NANOMATER
IAL
"A natural, incidental or 
manufactured material containing 
particles, in an unbound state or as 
an aggregate or as an agglomerate 
and where, for 50 % or more of the 
particles in the number size 
distribution, one or more external 
dimensions is in the size range 1 nm 
- 100 nm.”
European Commission (2011)
NANOSCA
LE
1 nm to 100 nm
NANOMATER
IAL
Same chemical composition but distinct  
physicochemical characteristics -> improved mechanical, 
optical, electric and magnetic properties
MACROMATER
IAL
Louro, Borges & Silva (2013)
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CELLUL
OSE
• Affordable
• Abundant
• Renewable
Rebouillat & Pla (2013)
Halib et al. (2017)
NANOCELLULOS
E
(ORIGINS)
• Plants (cellulose in association with lignin 
and hemicellulose)
• Bacteria (Acetobacter, Agrobacterium, 
Alcaligenes, Pseudomonas, Rhizobium e 
Sarcina)
• Fungi
• Algae
Halib et al. (2017)
NANOCELLULOS
E
(PRESENTATIONS)
• Nanocellulose nanocrystals
(CNC)
• Cellulose nanofibers (CNF)
• Diameter of 20 to 40 nm
• Length of micrometers
• High aspect ratio -similar to carbon 
nanotubes and asbestos
Ilves et al. (2018), Halib et al. (2017) & Nordli, Chinga-Carrasco, Rokstad & Pukstad (2016)
NANOCELLULOS
E
(BIOMEDICAL APPLICATIONS)
Wound dressings
• CNC and CNF 
• Burn wounds with excessive fluid 
loss
• Capability of maintaining a wet 
environment
• Delivery of bioactive substances 
such as antibiotics and anti-
inflammatory drugs 
Halib et al. (2017)
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NANOCELLULOS
E
(BIOMEDICAL APPLICATIONS)
Cartilage regeneration and 
replacement
• Cartilage is avascular, it has limited 
potential for healing
• Porous, mimics extracellular matrix 
and allows diffusion of nutrients
• CNF used as bioink for 3D printers
Halib et al. (2017)
NANOCELLULOS
E
(BIOMEDICAL APPLICATIONS)
Bone and periodontal 
regeneration
• Bone loss associated with age
• High aesthetic demands
• CNC and CNF
• Great mechanical properties for 
scaffolds and membranes
• Porous, mimics extracellular matrix 
and allows diffusion of nutrients and 
cell proliferation
Andrei, Dinischiotu, Didilescu, Ionita & Demetrescu (2017) & Halib et al. (2017)
NANOTOXICOLO
GY
• Greater presence means higher 
exposure risk in all phases of a 
nanomaterial’s life cycle
• Inhalation is the most important route of 
exposure
• CNF have a high aspect ratio
• Oral exposure is also a concern
• Because of their size these particles are 
able to reach organs such as the liver 
and the brain through the blood and 
lymphatic systems
Schmalz, Hickel, Landuyt & Reichl (2017), Carriere, Sauvaigo, Douki & Ravanat (2016) & Louro, Borges & Silva (2013)
NANOTOXICOLO
GY
• Nanomaterials are able to accumulate in 
practically every cell in the organism
• Once they penetrate the cells, some are 
able to enter the nucleus, having direct 
of indirect effects on the genetic 
material
• Two paradigms about nanotoxicology:
• Inflammatory potential
• Oxidative stress/genotoxicity
• Different physicochemical characteristics 
will alter pharmacokinetics and 
pharmacodynamics 
Fornaguera & García-Celma (2017), Carriere, Sauvaigo, Douki & Ravanat (2016) & Louro, Borges & Silva (2013)
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OBJECTIVE
• To analyze the safety of two CNF, 
obtained from Eucalyptus globulus, in 
bone producing cells – osteoblasts -, in 
order to be used in bone and periodontal 
regeneration procedures
• Evaluation of the cytotoxic effects 
through the MTT assay (Mosmann, 
1983)
• Evaluation of the genotoxic effects 
through the cytokinesis-block 
micronucleus assay (Fenech, 2007)
MATERIALS AND 
METHODS
NANOCELLULOSE PRODUCTION
• Two samples obtained from industrial bleached eucalyptus kraft 
pulp
1. CNF TEMPO – mechanical treatment followed by TEMPO-
mediated oxidation (Saito & Isogai, 2007)
2. CNF enzymatic – mechanical treatment followed by an enzymatic 
hydrolysis with endoglucanases (Tarrés et al., 2016)
MATERIALS AND 
METHODS
VIABILITY ASSAYS – MTT
• According to Mosmann (1983)
• Exposure to concentrations from 
1.5 to 50 µg/cm2
• 24h and 48h exposure
MG-63 (ATCC® CRL-1427™): human osteoblasts obtained from an osteosarcoma
GENOTOXICITY ASSAYS –
MICRONUCLEUS ASSAY
• According to Fenech (2007)
• Exposure to concentrations 
from 1.5 to 12.5 µg/cm2
RESULTS
NANOCELLULOSE PRODUCTION
Sample Batch Dry content (%) Yield (%) DP
TEMPO 1 0.83 82.4 1177
Enzymatic 1 0.83 8.2 185
TEMPO 2 0.77 100.0 364.5
Enzymatic 2 0.85 * 1472.3
*not determined
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MTT ASSAY – CNF TEMPO
24h exposure 48h exposure
MTT ASSAY – CNF ENZYMATIC
24h exposure
48h exposure
RESULTS
CYTOKINESIS-BLOCK MICRONUCLEUS ASSAY (CBMN)
CBMN – CNF TEMPO
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CBMN – CNF ENZYMATIC
DISCUSSION
• Non cytotoxic for all 
concentrations and 
exposure times, consistent 
with results obtained by Ventura, 
Lourenço, Sousa-Uva, Ferreira & 
Silva (2018), Souza et al. (2018),
Lopes, Martinez, Strømme & 
Ferraz (2017), Rashad, Mustafa, 
Heggset & Syverud (2017), 
Nordli, Chinga-Carrasco, Rokstad
& Pukstad (2016) & Pereira et al. 
(2013)
• Non-consistent with the results 
found by Ilves et al. (2018), who 
noticed a decrease in THP-1 
macrophages cell viability post 
CNF enzymatic exposure
DISCUSSION
• Higher frequency of 
micronucleated cells for the two 
lowest concentrations, exactly as 
reported by Ventura, Lourenço, 
Sousa-Uva, Ferreira & Silva (2018) 
in their study with A549 cells
exposed to Eucalyptus globulus
CNF TEMPO.
• Lima et al. (2012) noticed DNA 
damage, as well, but using other
assays.
• Catalán et al. (2016) didn’t report
higher frequency of micronuclei
following exposure to CNF TEMPO 
obtained from fir tree.
DISCUSSION
• Higher frequency of 
nucleoplasmatic bridges for the 
two lowest concentrations, not 
reported by any authors.
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CONCLUSION
• None of the studied CNF induced 
a loss of cell viability
• Both CNF demonstrated genotoxic 
potential, inducing the formation 
of chromosomal damage
• More endpoints need to be 
assessed in vitro, e.g., gene 
mutations, and in vivo, e.g. comet 
or micronucleus assay
• Although they show great 
potential to be used in the 
biomedical field, these two CNF 
still have to suffer changes in their 
production method in order to be 
considered a safe material
• Grupo de I&D em Toxicologia Genética
• ToxApp4NanoCELFI , 2018-2021 - PTDC/SAU-PUB/32587/2017
• ToxOmics - Centro de Investigação em Toxicogenómica e Saúde Humana -
UID/BIM/00009/2013
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